XML 30 R19.htm IDEA: XBRL DOCUMENT v3.7.0.1
Corrections to Previously Issued Consolidated Financial Statements (Tables)
9 Months Ended 12 Months Ended
Jun. 30, 2017
Sep. 30, 2016
Corrections to Previously Issued Consolidated Financial Statements [Abstract]    
Schedule of corrections and consolidated financial statements
    As of and for the Period Ended 
June 30, 2016
 
ITEMS   Previously 
Reported
    Adjustments     Restated  
                   
Consolidated Statements of Balance Sheets                  
Prepayment     3,500,000       (3,500,000 )     -  
Due to related party     -       6,500,000       6,500,000  
Accumulated deficit     (669,207 )     (10,000,000 )     (10,669,207 )
                         
Consolidated Statements of Operations and Comprehensive Loss                        
For the nine months ended June 30, 2016                        
Research and development expenses     -       10,000,000       10,000,000  
Net Loss     (352,796 )     (10,000,000 )     (10,352,796 )
Basic and diluted loss per share     (0.00 )     (0.05 )     (0.05 )
                         
Consolidated Statements of Cash Flow                        
Net loss from operating activities     (353,605 )     (10,000,000 )     (10,353,605 )
Issuance of common stock for compensation     -       897,521       897,521  
(Increase) decreases in prepayment     (3,496,185 )     3,500,000       3,815  
(Increase) decrease in due from related party     350,000       (350,000 )     -  
Increase (decrease) in due to related party     (22,517 )     6,500,000       6,477,483  
Increase (decrease) in due to shareholder     (46,586 )     46,586       -  
Net cash used in operating activities     (3,857,447 )     594,107       (3,263,340 )
                         
(Increase) decrease in due to shareholder     -       (46,586 )     (46,586 )
Proceeds from subscription receivable     -       350,000       350,000  
Proceeds from issuance of common stock     897,521       (897,521 )     -  
Net cash used in financing activities     2,947,521       (594,107 )     (2,353,414 )
 
Schedule of adjustments on previously reported consolidated financial statements
    Previously 
Reported on Form 10K
    Adjustments No.1     Adjustments No.2     Restated  
                         
Consolidated Balance Sheet                        
As of September 30, 2016                                
Due to related party     -       6,500,000       -       6,500,000  
Total Liabilities     56,470       6,500,000       -       6,556,470  
Additional paid-in capital     4,733,401       -       60       4,733,461  
Accumulated deficit     (4,823,401 )     (6,500,000 )     -       (11,323,401 )
Total equity (deficit)     120,882       (6,500,000 )     -       (6,379,118 )
                                 
Consolidated Statements of Operations and Comprehensive Loss                                
For the year ended September 30, 2016                                
Selling, general and administrative expenses     4,497,263       (3,500,060 )     60       997,263  
Research and development expenses     -       10,000,000       -       10,000,000  
Net loss from operations     (4,497,295 )     (6,499,940 )     (60 )     (10,997,295 )
Loss from continuing operations before income taxes     (4,506,963 )     (6,499,940 )     (60 )     (11,006,963 )
Net Loss     (4,507,799 )     (6,499,940 )     (60 )     (11,007,799 )
Basic and diluted loss per share     (0.00 )     (0.06 )     (0.00 )     (0.06 )
Consolidated Statements of Cash Flow                                

For the year ended September 30, 2016

                               
Net loss from continuing operations     (4,507,799 )     (6,499,940 )     (60 )     (11,007,799 )
Issuance of common stock for compensation     1,295,324       (60 )     60       1,295,324  
(Decrease) increase in due to related party     (22,517 )     6,500,000               6,477,483  
                                 

Consolidated Statements of Cash Flow

                               
For the year ended September 30, 2015                                
Net cash used in operating activities     (517)        -       (198 )     (715 )
 

ITEMS

  Previously 
Reported on Form 10K
    Adjustments No.1     Adjustments No.2     Restated  
                         
Consolidated Balance Sheet                        
As of September 30, 2016                        
Due to related party     -       6,500,000       -       6,500,000  
Total Liabilities     56,470       6,500,000       -       6,556,470  
Additional paid-in capital     4,733,401       -       60       4,733,461  
Accumulated deficit     (4,823,401 )     (6,500,000 )     -       (11,323,401 )
Total equity (deficit)     120,882       (6,500,000 )     -       (6,379,118 )
                                 
Consolidated Statements of Operations and Comprehensive Loss                                
For the year ended September 30, 2016                                
Selling, general and administrative expenses     4,497,263       (3,500,060 )     60       997,263  
Research and development expenses     -       10,000,000       -       10,000,000  
Net loss from operations     (4,497,295 )     (6,499,940 )     (60 )     (10,997,295 )
Loss from continuing operations before income taxes     (4,506,963 )     (6,499,940 )     (60 )     (11,006,963 )
Net Loss     (4,507,799 )     (6,499,940 )     (60 )     (11,007,799 )
Basic and diluted loss per share     (0.00 )     (0.06 )     (0.00 )     (0.06 )
                                 

Consolidated Statements of Cash Flow

For the year ended September 30, 2016

                               
Net loss from continuing operations     (4,507,799 )     (6,499,940 )     (60 )     (11,007,799 )
Issuance of common stock for compensation     1,295,324       (60 )     60       1,295,324  
(Decrease) increase in due to related party     (22,517 )     6,500,000               6,477,483  
                                 
Consolidated Statements of Cash Flow                                
For the year ended September 30, 2015                                
Net cash used in operating activities     (517 )     -       (198 )     (715 )